of many projects although the Company has already been hired. The Company’s subsidiaries have increased work deliveries compared to the same period of previous year. (2) Cost of sales In the second
numerous of other countries. Therefore, our 2020 Quarter 4’s total revenues surpassed our 2019’s total revenue of the same quarter as the figures are Baht 535.69 million and Baht 534.40 million respectively
sales staffs, advertising media fee for product promotion, distribution fee paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of company’ s products in the
income, and gains from foreign exchange, and the increase in other income is mainly attributable to the increase in unrealized gain from foreign exchange, which is not related to the Company’s core
Company operates with our corporate strategy to balance its business units by diversification in revenue structure and risk into 3 main businesses supporting each other and focusing on Healthy & Beauty
. Chatchai Pokogwai and Mrs. Lakana Ratwongsakul, two out of four directors jointly sign with the company’s seal affixed.” New “Mr. Shine Bunnag, Mr. Chatchai Pokogwai and Mrs. Lakana Ratwongsakul, two out of
Company’s consolidated financial statement on March 31, 2020 ( 57,355.96 million Baht) . There are no new shares issued to compensate for the acquisition of assets and the Company had asset acquisition
exchange, and the increase in other income is mainly attributable to the increase in unrealized gain from foreign exchange, which is not related to the Company’s core business. Cost of sales and services
material due to increase of production order and decreasing in bank overdraft and short-term borrowings from financial institution due to the repayment. In conclusion, the Company operates with our corporate
, employee expenses, utilities and audit fees. Financial Cost (9 months) For quarter 3/2020, the Company’s finance cost is Baht 29.57 million dramatically increased from quarter 3/2019 by Baht 15.70 million